PMID-sentid Pub_year Sent_text compound_name comp_offset prot_official_name organism prot_offset 1831441-8 1991 125I-laminin binding to lymphoid or myeloid leukemic cells was mainly inhibited by P1 fragments, whereas granulocytes and differentiated HL60 cells displayed a dual binding pattern for laminin fragments P1 and E8. 125i-laminin 0-12 crystallin gamma F, pseudogene Homo sapiens 203-212 2522914-5 1989 All of the lines which interacted with murine NK cells as indicated by sensitivity to killing and/or by ability to "cold-target" compete with the killing of sensitive Yac-1 cells were able to bind 125I-laminin and to respond to laminin in an aggregation assay. 125i-laminin 197-209 ADP-ribosyltransferase 1 Mus musculus 167-172 2946778-1 1987 Activated human polymorphonuclear leukocytes (PMN) isolated from peripheral blood specifically bind 125I-laminin after stimulation with phorbol 12-myristate 13-acetate (PMA) or f-Met-Leu-Phe (FMLP) at 37 degrees C. Changes in laminin receptor expression are stimulus dose dependent at both chemotactic (10(-10) M to 10(-6) M) concentrations of FMLP, and secretory (greater than 5 ng/ml) levels of PMA. 125i-laminin 100-112 formyl peptide receptor 1 Homo sapiens 192-196 2946778-1 1987 Activated human polymorphonuclear leukocytes (PMN) isolated from peripheral blood specifically bind 125I-laminin after stimulation with phorbol 12-myristate 13-acetate (PMA) or f-Met-Leu-Phe (FMLP) at 37 degrees C. Changes in laminin receptor expression are stimulus dose dependent at both chemotactic (10(-10) M to 10(-6) M) concentrations of FMLP, and secretory (greater than 5 ng/ml) levels of PMA. 125i-laminin 100-112 formyl peptide receptor 1 Homo sapiens 344-348